Cargando…
Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation
Neuroblastoma is the most common extracranial solid tumor in children. MYCN amplification is detected in almost half of high-risk cases and is associated with poorly differentiated tumors, poor patient prognosis and poor response to therapy, including retinoids. We identify the aryl hydrocarbon rece...
Autores principales: | Chaudhry, Kanita A., Jacobi, Justine J., Gillard, Bryan M., Karasik, Ellen, Martin, Jeffrey C., da Silva Fernandes, Tatiane, Hurley, Edward, Feltri, Maria Laura, Attwood, Kristopher M., Twist, Clare J., Smiraglia, Dominic J., Long, Mark D., Bianchi-Smiraglia, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654598/ https://www.ncbi.nlm.nih.gov/pubmed/38026169 http://dx.doi.org/10.1016/j.isci.2023.108303 |
Ejemplares similares
-
Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
por: Wu, Pei-Yi, et al.
Publicado: (2014) -
Correction: Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
Publicado: (2014) -
CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020) -
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023) -
The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
por: Misiak, Danny, et al.
Publicado: (2021)